Literature DB >> 27187028

Health utility of patients with Crohn's disease and ulcerative colitis: a systematic review and meta-analysis.

Krzysztof Piotr Malinowski1, Paweł Kawalec1.   

Abstract

INTRODUCTION: The aim of this systematic review was to collect and summarize the current data on the utilities of patients with Crohn's disease (CD) and ulcerative colitis (UC). AREAS COVERED: A meta-analysis of the obtained utilities was performed using a random-effects model and meta-regression by the disease type and severity. A bootstrap analysis was performed as it does not require assumption on distribution of the data. The highest utility among patients with CD and UC was observed when the diseases were in remission. The meta-regression analysis showed that both disease severity and an instrument/method/questionnaire used to obtain utilities were significant predictors of utility. Utility was the lowest for severe disease and the highest for disease in remission, the association was more notable in patients with CD compared with UC. Expert commentary: The issue of patients' utility is important for healthcare decision makers but it has not been fully investigated and requires further study.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; quality of life; systematic review; ulcerative colitis; utility

Mesh:

Year:  2016        PMID: 27187028     DOI: 10.1080/14737167.2016.1190644

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  6 in total

1.  Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.

Authors:  Vasileios Fragoulakis; Rossana Roncato; Chiara Dalle Fratte; Fabrizio Ecca; Marina Bartsakoulia; Federico Innocenti; Giuseppe Toffoli; Erika Cecchin; George P Patrinos; Christina Mitropoulou
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

2.  A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values.

Authors:  Stavros Petrou; Joseph Kwon; Jason Madan
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

3.  An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease.

Authors:  Naazish S Bashir; Thomas D Walters; Anne M Griffiths; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-04-27

4.  The health-related quality of life in Iranian patients with COVID-19.

Authors:  Cyrus Alinia; Safura Yaghmaei; Farman Zahir Abdullah; Asad Ahmadi; Nasrin Samadi; Sima Pourteymour; Hossein Safari; Hassan Mahmoudi; Ghobad Moradi; Bakhtiar Piroozi
Journal:  BMC Infect Dis       Date:  2021-05-20       Impact factor: 3.090

Review 5.  Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.

Authors:  Raed A Joundi; Joel Adekanye; Alexander A Leung; Paul Ronksley; Eric E Smith; Alexander D Rebchuk; Thalia S Field; Michael D Hill; Stephen B Wilton; Lauren C Bresee
Journal:  J Am Heart Assoc       Date:  2022-06-22       Impact factor: 6.106

6.  Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn's disease in China.

Authors:  Ji-Hao Shi; Liang Luo; Xiao-Li Chen; Yi-Peng Pan; Zhou Zhang; Hao Fang; Ying Chen; Wen-Dong Chen; Qian Cao
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.